Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein sulfhydryl groups, also known as protein thiols, are highly reactive functional groups found on the side chains of cysteine residues within proteins. These groups are essential for a wide array of biological processes, including the formation of stabilizing disulfide bridges, the coordination of metal ions, and the execution of catalytic mechanisms in enzymes such as cysteine proteases (Source: UniProt). They also act as critical mediators of redox signaling, where their oxidation state changes in response to cellular oxidative stress, influencing protein function and downstream pathways (Source: PubMed, PMID: 28844921). In the context of drug development, protein sulfhydryl groups are the primary targets for covalent inhibitors, which form stable chemical bonds with specific cysteines to achieve high selectivity and prolonged therapeutic effects, as seen with drugs like Ibrutinib and Afatinib (Source: Nature Reviews Drug Discovery). However, the inherent nucleophilicity of these groups can lead to non-specific binding with off-target proteins, potentially causing toxicity or triggering immune responses through the formation of hapten-protein adducts (Source: NIH). Consequently, monitoring the integrity and modification of protein thiols serves as a vital biomarker for assessing oxidative damage and drug safety in clinical settings (Source: StatPearls). The therapeutic modulation of these groups is a cornerstone of modern precision medicine, particularly in the design of targeted covalent inhibitors for oncology and inflammatory diseases (Source: Journal of Medicinal Chemistry).
Drugs target these groups through covalent modification (alkylation or acylation), redox modulation, or metal chelation, often resulting in the irreversible inhibition of the host protein's function.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein sulfhydryl groups on cysteine residues (PSH) (PSH).